Xilio Therapeutics, Inc. ( XLO) - Stock Earnings
XLO Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 13, 2026, midnight | — / — | — | — / — | — |
XLO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 10.4 million USD | 13.7 million USD |
| 2026Q1 | -9.5 million USD | 12.6 million USD |
| 2026Q2 | -6.4 million USD | 18.7 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
XLO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -76.4 million USD | — USD |
| 2024 | -58.2 million USD | 6.3 million USD |
| 2025 | -35.0 million USD | 43.8 million USD |
| 2026 Est. | — | — |
XLO
Price: $9.50
52 week price:
Earnings Per Share: -0.32 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 18100
Market Capitalization: 60.3 million